Aptus Value Housing Finance India Ltd Q2 FY27 Results Analysis: PAT Jumps 18%, Credit Costs Breach Guidance
Cofacto Research
Published November 04, 2026
4 min read
Positive
Aptus Value Housing Finance India Ltd's Q2 FY27 numbers came in strong, with revenue of Rs. 634.67 Cr (+14.63% YoY) and PAT growth of +18.02% YoY. Here's a quick read of what worked, what to watch, and what management said.
Quick Details| Results date | November 04, 2026 |
|---|
| Revenue (Q2) | Rs. 634.67 Cr (+14.63% YoY) |
|---|
| PAT (Q2) | Rs. 267.38 Cr (+18.02% YoY) |
|---|
| EPS (Q2) | Rs. 5.34 (+17.62% YoY) |
|---|
Quarter Snapshot
Consolidated PAT grew 18.02% YoY to Rs.267.38 Cr with net income margin up 19.18% YoY, powered by finance costs rising only 3.91% against 16.51% interest income growth, and ROE of 20.07% is on track against the 20%+ target. The key tension is credit cost: impairment rose 58.19% YoY in H1 with the proxy at 0.74% annualized, above the guided 0.5% ±10 bps band, while opex growth of 29.77% lifted cost-to-income by 138 bps. AUM and disbursement guidance cannot be assessed from the filing, leaving the 22-24% AUM growth target unverified this quarter.
Q2 FY27 Expectations vs Results
| Driver | Expected before results | What happened | Verdict |
|---|
| AUM/disbursements "set to re-enter or press the guided 22–24% band" | direction | AUM/disbursements not disclosed in the filing; loans +4.80% over H1; total income +14.90% YoY H1 — filing basis | Not observable |
| Spread "flat-to-slightly-compressing"; CoF broadly stable | direction | Spread % not disclosed; finance costs +3.91% vs interest income +16.51%; net income margin +19.18% YoY — better than the compressing case on the computable basis | Partially |
| Credit cost hinges on NBFC normalization vs 0.5%±10 bps | direction | Impairment +31.98% YoY Q2; proxy 0.74% H1; GNPA flat, PCR up to 25.50% — stock stable, run-rate elevated | Partially |
| No adverse sector regulation inside the window | direction | Filing shows routine RBI/NHB framework compliance; unmodified review opinion | Played out |
| First Interim Dividend (record date Nov 13) | declared | Rs.2/share declared; Rs.100.17 Cr; 18.96% of H1 PAT | Played out |
| Reconcile GNPA 1.70% (presentation) vs 1.42% (Q1 filing) | reconciliation | Q2 filing basis: 1.52% GNPA / 1.14% NNPA / 25.50% PCR — basis gap persists, unexplained in the filing | Partially |
| NHB Rs.500 Cr refinance drawdown; Q2 branch additions (20–23); opex/AUM vs 2.6–2.8% | status | None addressed in the filing (AUM-basis ratios not computable) — remain open for the call | Not observable |
Management Guidance vs Delivery
| What management said | What happened | Verdict |
|---|
| AUM growth 22–24% FY27 (~Rs.16,000 Cr) | AUM not disclosed in the filing; loans +4.80% over H1; total income +14.90% YoY H1 | Too Early |
| ROE 20%+ | 20.07% annualized (2×H1 consol PAT / avg net worth) | On Track |
| First interim dividend FY27 — to be considered Nov 4 | Declared Rs.2/share | Met |
Key Numbers, Quarter by Quarter
| Metric | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 |
|---|
| AUM (Rs. Cr) | 11,767 | 12,330 | 13,107 | 13,648 | not disclosed |
| Disb. (Rs. Cr) | 963 | 1,030 | 1,242 | 1,053 | not disclosed |
| PAT (Rs. Cr) | 226.55 | 239 | 261 | 260.94 | 267.38 |
| RoA % | 7.9 | 7.9 | 8.2 | 7.8 | 7.82 |
| RoE % | 20.0 | 20.2 | 21.2 | 20.4 | 20.07 |
| Spread % | 8.9 | 8.9 | 9.0 | 9.0 | not disclosed |
| CoB % | 8.4 | 8.3 | 8.1 | 8.0 | not disclosed |
| Branches | 321 | 335 | 339 | 372 | not disclosed |
Key Investment Insights
Key Positives
- Consolidated PAT grew 18.02% YoY to Rs.267.38 Cr in Q2; H1 PAT grew 18.51% YoY to Rs.528.32 Cr
- Net income margin grew 19.18% YoY to Rs.463.22 Cr as finance costs rose only 3.91% YoY against 16.51% interest income growth
- PPOP grew 16.59% YoY to Rs.364.17 Cr in Q2
- GNPA stable at 1.52% with PCR on stage-3 assets improved to 25.50% from 25.0% at Q1; LCR at 196.29%
- Loans grew 4.80% in H1 to Rs.12,501.72 Cr while gross D/E improved to 1.53 from 1.56 and liquidity buffer rose 25.02% to Rs.1,038.78 Cr
- Annualized consolidated ROE at 20.07%, on track against management's 20%+ target
- First interim dividend of Rs.2/share declared (Rs.100.17 Cr, 18.96% of H1 PAT)
- Subsidiary Aptus Finance India contributed Rs.66.66 Cr (24.93% of consolidated PAT) vs Rs.24.69 Cr a year ago
Risk Factors
- Impairment charges rose 31.98% YoY in Q2 and 58.19% YoY in H1; H1 impairment already equals 73.76% of FY26's full-year charge, with the annualized run-rate ~47% above FY26
- Credit-cost proxy of 0.74% H1 annualized (0.76% Q2) runs above the guided 0.5% ±10 bps band
- Opex grew 29.77% YoY, lifting cost-to-income to 15.21% in H1 from 13.83% in H1 FY26
- Standalone PAT declined 0.56% YoY due to a base effect in other income (Rs.35.09 Cr year-ago vs Rs.11.37 Cr now)
- GNPA disclosure basis gap between presentation (1.70% at Q1) and filing (1.42% at Q1) remains unexplained in the filing
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings
Login Now